David Gattas

Clinical Associate Professor David Gattas is affiliated with the University of Sydney's Central Clinical School, specializing in Intensive Care Medicine. His research focuses on critical care innovations, particularly extracorporeal membrane oxygenation (ECMO), sepsis management, fluid therapy, and acute kidney injury. He has contributed to high-impact studies on ECMO protocols, oxygen management in critically ill patients, and the efficacy of vasopressors like metaraminol.

His work spans clinical trials, observational studies, and systematic reviews, addressing topics such as ventilator weaning practices, anticoagulation strategies in renal replacement therapy, and outcomes of ECMO use in pandemic scenarios (e.g., H1N1 influenza). Notable grants include the NHMRC-funded PLUS trial evaluating fluid therapies in ICUs.

Dr. Gattas collaborates across Australian and international teams, advancing ECMO practices and critical care standards. His research emphasizes translational outcomes, including cost-effectiveness analyses of ECPR (extracorporeal cardiopulmonary resuscitation) and quality-of-life assessments for ECMO survivors.